Nomura Micro Science Co., Ltd. (6254) AI Stock Analysis

• Market Cap: ¥104.23B
• Dividend Yield: 3.28%
• Average Volume (3M): 1.07M
• Price to Earnings (P/E): 9.7
• Beta (1Y): 1.61
• Revenue Growth: 31.96%
• EPS Growth: 26.36%
• Country: JP
• Employees: 545
• Sector: Industrials
• Sector Strength: 93
• Industry: Industrial - Machinery
• EPS (TTM): 215.84
• Shares Outstanding: 40,608,000
• 10 Day Avg. Volume: 828,600
• 30 Day Avg. Volume: 1,067,653
• PEG Ratio: 0.06
• Price to Book (P/B): 2.48
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,200.00
• Price Target Upside: -16.29% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 77 Outperform
• Price Target: ¥3,220.00 ▲(22.53%Upside)

Nomura Micro Science Co., Ltd. scores well due to its robust financial performance and strong technical indicators, both suggesting a healthy and growing company. The stock's valuation metrics add further appeal, highlighting potential undervaluation. However, attention to cash flow management is necessary to mitigate future risks.

Nomura Micro Science Co., Ltd. Business Overview & Revenue Model

Company Description

Nomura Micro Science Co., Ltd. is a Japan-based company primarily engaged in the development, manufacturing, and sales of ultrapure water production systems and related equipment. The company operates in sectors including semiconductor, pharmaceutical, and food industries, offering high-precision water filtration systems and maintenance services to ensure optimal performance. Nomura Micro Science is recognized for its technological expertise in water purification and its dedication to providing solutions that meet stringent industry standards.

How the Company Makes Money

Nomura Micro Science Co., Ltd. generates revenue through the sale of its ultrapure water production systems and related equipment. The company's key revenue streams include the manufacturing and installation of water purification systems tailored to the needs of industries such as semiconductors, pharmaceuticals, and food processing, which require high-purity water for their operations. Additionally, the company earns from providing maintenance and support services for its installed systems, ensuring long-term client engagement and system efficiency. Strategic partnerships with leading technology and industrial companies also play a significant role in its earnings, as these alliances help in expanding market reach and technological advancements.

Nomura Micro Science Co., Ltd. Financial Statement Overview

Summary

Nomura Micro Science Co., Ltd. demonstrates robust financial performance with strong revenue and profit growth. The balance sheet reflects financial stability with a moderate debt-to-equity ratio, but the company must focus on improving cash flow generation to support long-term objectives.

Income Statement

Nomura Micro Science Co., Ltd. has exhibited strong revenue growth, with a notable increase in total revenue from 2024 to 2025. Gross profit and net profit margins have improved, indicating enhanced operational efficiency and profitability. The EBIT and EBITDA margins are solid, reflecting effective cost management and a healthy earnings profile.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio, suggesting a balanced approach to leveraging. The return on equity is strong, driven by rising net income and shareholder equity. The equity ratio indicates a stable financial structure, though the increase in total debt in recent years warrants attention.

Cash Flow

The cash flow analysis reveals challenges, with negative free cash flow and operating cash flow over the recent periods. However, there is a significant improvement in free cash flow from 2024 to 2025. The company needs to address cash flow generation to ensure sustainable growth.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	96.36B	73.02B	49.60B	31.90B	30.36B
Gross Profit	21.11B	15.41B	10.37B	7.66B	7.13B
EBITDA	16.95B	11.72B	7.70B	4.78B	3.77B
Net Income	10.20B	7.98B	5.81B	3.29B	2.62B
Balance Sheet
Total Assets	116.78B	70.60B	41.92B	27.09B	24.76B
Cash, Cash Equivalents and Short-Term Investments	17.33B	12.14B	14.12B	10.08B	9.86B
Total Debt	53.20B	22.40B	3.47B	2.69B	2.63B
Total Liabilities	79.77B	41.68B	20.52B	11.16B	11.57B
Stockholders Equity	37.01B	28.92B	21.40B	15.93B	13.19B
Cash Flow
Free Cash Flow	-22.31B	-19.02B	3.65B	771.34M	5.80B
Operating Cash Flow	-18.73B	-18.66B	4.68B	1.13B	5.96B
Investing Cash Flow	-4.22B	386.99M	64.81M	134.01M	-433.48M
Financing Cash Flow	27.18B	17.45B	-24.90M	-881.82M	-937.84M

Nomura Micro Science Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2628.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6254, the sentiment is Positive. The current price of 2628 is above the 20-day moving average (MA) of 2453.05, above the 50-day MA of 2366.08, and above the 200-day MA of 2269.47, indicating a bullish trend. The MACD of 48.30 indicates Negative momentum. The RSI at 72.44 is Negative, neither overbought nor oversold. The STOCH value of 88.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6254.

Nomura Micro Science Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6340	81 Outperform	¥97.39B	8.98		2.56%	16.74%	30.37%
6482	79 Outperform	¥21.17B	12.50		3.22%	15.17%	36.74%
6254	77 Outperform	¥104.23B	9.71		3.28%	31.96%	26.36%
6490	77 Outperform	¥92.21B	10.96		3.24%	-1.05%	-23.08%
6486	74 Outperform	¥111.31B	21.08		4.19%	0.68%	-32.97%
6284	74 Outperform	¥98.49B	13.71		2.30%	17.01%	16.10%
Sector *	65 Neutral	$11.14B	16.13	4.60%	2.08%	3.17%	-25.97%

Nomura Micro Science Co., Ltd. Corporate Events

Nomura Micro Science Revises FY2025 Earnings Report Due to Cash Flow Errors

Nomura Micro Science Co., Ltd. announced corrections to its FY2025 March Earnings Report due to errors in the consolidated cash flow statements. The corrections indicate a change in cash flows from operating and investing activities, impacting the company’s financial reporting and potentially affecting stakeholders’ perceptions of its financial health.

Nomura Micro Science Adjusts Loan Repayment Schedule

Nomura Micro Science Co., Ltd. has announced a change in the repayment dates for loans related to its large water treatment systems project. The repayment dates have been extended to February 27, 2026, from the original dates in mid-2025. This decision, made to better align with the company’s cash flow situation, is expected to have a minor impact on the company’s performance for FY2026.

Nomura Micro Science Announces Dividends of Surplus

Nomura Micro Science Co., Ltd. announced its decision to implement dividends of surplus with a record date of March 31, 2025. This decision aligns with the company’s medium-term management plan to maintain a balanced cash allocation and a target dividend payout ratio of 30%. The total annual dividends for the current term will be 80 yen per share, reflecting the company’s commitment to stable shareholder returns and a sound financial foundation.

Nomura Micro Science Reports Strong FY2025 Results Amid Upcoming Challenges

Nomura Micro Science Co., Ltd. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a significant increase in net sales and profits compared to the previous year. The company conducted a 4-for-1 share split, which impacted earnings per share calculations, and announced a forecasted decline in net sales and profits for the next fiscal year, indicating potential challenges ahead.